Breaking News Instant updates and real-time market news.

BBBY

Bed Bath & Beyond

$44.00

1.01 (2.35%)

10:09
10/05/16
10/05
10:09
10/05/16
10:09

Bed Bath & Beyond tests range highs at $45 area

The shares are up over 2% to $44.96 at time of writing. A move above $45 and more especially $46.50 would clear resistance in the trading range that has been in place since May of this year. Support is at $44. A breakout above the range high could signal a new bullish trend developing longer-term.

BBBY Bed Bath & Beyond
$44.00

1.01 (2.35%)

06/16/16
LBOW
06/16/16
INITIATION
LBOW
Neutral
Bed Bath & Beyond initiated with a Neutral at Longbow
06/16/16
06/16/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Chipotle (CMG) initiated with a Buy at Buckingham with analyst John Zolidis saying investors should take advantage of the dislocation in the business and stock price following recent food safety issues to purchase one of the highest quality companies in the sector. 2. Bed Bath & Beyond (BBBY) initiated with a Neutral at Longbow. 3. Shake Shack (SHAK) initiated with a Buy at Buckingham. 4. CSX (CSX), Norfolk Southern (NSC), and Union Pacific (UNP), initiated with a Perform at Oppenheimer. 5. Kansas City Southern (KSU) initiated with an Outperform at Oppenheimer. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/23/16
DBAB
06/23/16
NO CHANGE
Target $42
DBAB
Hold
Bed Bath & Beyond price target lowered to $42 from $45 at Deutsche Bank
Deutsche Bank analyst Mike Baker noted that Bed Bath & Beyond reported sales, comps and EPS that were all below expectations and points out that the company made "some subtle and not so subtle" changes to guidance, including the fact that it cut its comp guidance. Baker maintain a Hold rating on BB&B shares, citing valuation, and lowered his price target on the stock to $42 from $45.
06/23/16
OPCO
06/23/16
NO CHANGE
OPCO
Perform
Bed Bath & Beyond continues to struggle, says Oppenheimer
Oppenheimer analyst Brian Nagel says Bed Bath & Beyond's weaker than expected Q1 results and more downbeat fiscal year 2016 outlook reflect ongoing struggles at the company. While the analyst remains optimistic that over the longer term Bed, Bath & Beyond will find the right formula to compete effectively online while protecting industry leading margins, he expects the current transition at the company to persist for a while and fuel choppiness in results. Nagel reiterates a Perform rating on the shares.

TODAY'S FREE FLY STORIES

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.